Media Mentions

Outsourcing Pharma recently spotlighted the Ivy Center's groundbreaking clinical trial on AZD1390 for recurrent glioblastoma patients. The Ivy Center unveiled promising initial results, indicating that AZD1390 may act as a potent radio-sensitizer in human glioblastoma cases. This discovery marks the first instance where AZD1390's potential efficacy in enhancing radiation therapy for glioblastoma has been documented in humans. These results highlight the Ivy Center's commitment to pioneering advancements in glioblastoma treatment.

August 25th marked five years since our nation lost Senator John McCain to a deadly glioblastoma brain tumor. The Ivy Brain Tumor Center honors Senator McCain and all those affected by this devastating disease by remaining committed to our mission to find a cure for patients with brain tumors. Andy McCain, son of John McCain and avid supporter of the Ivy Center, appeared on 12News to talk about his father and how the family remembers him.

Discover five years of transformative progress against glioblastoma through ABC15's illuminating coverage of the Ivy Brain Tumor Center. They delve into innovative treatments, patient stories like Heather Knies', and the visionary leadership of Director Dr. Nadar Sanai. Read the full coverage here.

OncLive On Air has a discussion with Dr. Nader Sanai, director of the Ivy Brain Tumor Center. Delve into intricate insights about meningiomas, including prevalence, malignant grading, common symptoms, and innovative treatment modalities for high-grade cases.

Oncology Nursing News highlights Jacki Garcia, RN, BSN, CNRN, and Kristen Hendrickson, BA, RN, and their roles within Phase 0 trials and impact on personalized treatments for brain tumor patients. Join them as they explore the invaluable work of the Ivy Center, providing hope and potential treatment options to those in need.

In honor of Glioblastoma Awareness Day, Ivy Center patient, Jenn Ortiz, joins 12 News with Dr. Shwetal Mehta to discuss the importance of raising awareness and funds for this devastating disease.

The Ivy Brain Tumor Center, a research center dedicated solely to the discovery of a cure for brain tumors, will open the doors to its new headquarters later this year. North Central News covers the construction progress and shares more about the new building.

Jacki Garcia, RN, BSN, CNRN, and Kristin Hendrickson, BA, RN, shed light on Phase 0 trials and their impact on personalized treatments for brain tumor patients. Join them as they explore the invaluable work of the Ivy Center, providing hope and potential new treatment options to those in need.

Yoshie Umemura, MD, was recently appointed as Chief Medical Officer of the Ivy Brain Tumor Center and Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute. Dr. Umemura plans to build on the Ivy Center’s clinical trials program and translate those findings directly into patient care.

The Ivy Brain Tumor Center joins Glioblastoma Research Organization's podcast, "Glioblastoma aka GBM" to discuss the journey in finding a cure for brain cancer. Featuring Catherine Ivy, the driving force behind the quest for a cure and renowned neurosurgeon, Dr. Nader Sanai, they delve into the remarkable world of brain cancer research